Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.
about
Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysisTranscatheter Aortic Valve Replacement in Lower Surgical Risk Patients: Review of Major Trials and Future Perspectives.Future of transcatheter aortic valve implantation - evolving clinical indications.Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement.Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients.Late Paravalvular Aortic Regurgitation: Migration of the Valve or Late Recoil?Resource utilization and procedure-related costs associated with transfemoral transcatheter aortic valve replacement.Access Options for Transcatheter Aortic Valve Replacement in Patients with Unfavorable Aortoiliofemoral Anatomy.Prosthesis-Patient Mismatch After Aortic Valve Replacement.How TAVI registries report clinical outcomes-A systematic review of endpoints based on VARC-2 definitions.Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure deviceTranscatheter aortic valve replacement with the SAPIEN 3 valve: preparing the field for the final expansion.Rapid adoption of transcatheter aortic valve replacement in intermediate- and high-risk patients to treat severe aortic valve stenosis.Shifting paradigms for treatment of symptomatic aortic stenosis in lower risk populations: role of a newer generation balloon-expandable transcatheter aortic valve implantation device.Transcatheter aortic valve implantation at institutions without cardiovascular surgery departments: many questions still linger before a paradigm shift.Transcatheter aortic valve replacement: favorable clinical outcomes support role in intermediate risk surgical patientsTranscatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.The 3 S's of the Sapien balloon expandable valve.From CoreValve to Evolut PRO: Reviewing the Journey of Self-Expanding Transcatheter Aortic Valves.Pros and cons of transcatheter aortic valve implantation (TAVI).The Lotus dilemma-respond to paravalvular leakage, but not answering pacemaker implantations?Comparison of Different Invasive Hemodynamic Measurements as a Prediction Tool for Mortality after Transcatheter Aortic Valve Replacement in Men: A Retrospective Observational Study.Comprehensive geriatric assessment in patients undergoing transcatheter aortic valve implantation - results from the CGA-TAVI multicentre registry.Transcatheter aortic valve implantation in patients on corticosteroid therapy.Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.Evolving Indications for Transcatheter Aortic Valve Interventions.Comparison of valve performance of the mechanically expanding Lotus and the balloon-expanded SAPIEN3 transcatheter heart valves: an observational study with independent core laboratory analysis.Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.Recent advances in understanding and managing aortic stenosis.Contemporary transcatheter aortic valve replacement with third-generation balloon-expandable versus self-expanding devices.Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.Progression and Prognosis of Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation.Early versus newer generation devices for transcatheter aortic valve implantation in routine clinical practice: a propensity score matched analysis.Insight from a large real-world cohort of patients: does it confirm the results of the randomized trials?TAVR in 2017-What we know? What to expect?SOURCE 3 at 1 year: what can we learn?From Cinderella to centre stage: valvular heart disease on the move.Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?
P2860
Q28278896-5660FEF1-C13A-4570-8D51-114844DA73F2Q30275988-41E93AEF-766D-48FA-B965-B4FD9AE0ED60Q38610660-F29D13E4-EBB5-490F-B2A7-C22669F1DB09Q38692282-204D09C7-45D2-4F70-B05D-306C34785A86Q38708550-57446EC6-5651-4642-8C9C-3F03BFCE5E0FQ38771029-DF753E05-5D06-49C5-BCF2-34B1C579E94BQ38775414-C5497ADC-7EF3-4A23-BDAC-7F1CA9688675Q38917800-9D1A13E6-F5E5-4EF1-90B9-FD7B0DDDA787Q38960159-CE1468C9-7FE8-4363-AF11-65C0546759A2Q38968272-AE6280A3-958A-4B67-83B3-C7CB1BE7E2DEQ41074091-E4FA85A6-41AF-424C-8C0E-A609017A02F8Q41512519-40AB10CF-6A86-431B-BF98-064B314DED96Q42328750-3E8E5611-D61F-4521-8CDF-24F42549738EQ42332748-DFE0BE1B-F88A-46D3-AE11-3C699BD66453Q42333626-79522CDC-B815-49DD-898C-40DFC1C4C625Q42384657-73E2356A-2340-4A9F-8117-C71AD1507183Q42384702-F55AF557-40E0-4064-A1B0-98518D7C79CBQ44263335-6A63C0BD-E0A0-4A4A-A9EB-B3D1D639A001Q44901012-1D558120-8935-4FD3-9EE2-7BE4416E8331Q45329695-826E5BA0-15B6-4E3A-BD9F-DD11A24ABC46Q47125397-C603CD08-17C2-4E34-9E93-2AFF3BE95148Q47154854-5FE5480A-D152-4C6A-AB3B-CCFDADF7E44FQ47166045-27EB42EB-2D4B-4CF5-A973-771E375BA9DFQ47200137-224DA094-F23C-4FBF-9633-94DF8E9DA9B8Q47366339-5A16537A-FE01-487A-8818-ABE59B579B67Q47412405-A6D70F71-5D77-48EA-A03E-CE646D96F040Q47642882-BD818838-84AF-48C9-A889-33462FA47D21Q47672900-A9B1A28C-6623-4FA0-B174-92F5FA0792CDQ47896742-31308EED-8096-460B-9067-B5BD5D968CF6Q48148754-9752AE21-257E-4243-8B0B-0D8AAF00E2A9Q48155124-FC329B9E-69C6-4FA2-85C5-561A8A06A91CQ48159613-0F6720DA-FBDB-4721-A746-BEBAFFBAA918Q48317954-A0BE34A3-0CC7-43F4-BA1F-8EA4FF7D3F45Q49165113-F6E16CFD-E013-416A-A24C-246150B20AB3Q49280753-27FFC2E8-F188-46CD-B798-ABCDE14638D9Q49332765-C3B2C494-AC7A-484E-87E0-745500FC5217Q49516546-4C20A931-4989-4238-9062-FF4A79B8E0D1Q50087817-F583FD04-8896-410C-92D6-89935BEF55F7Q50087865-03440943-2756-4939-83B4-5BDE8FFF5713Q50094196-64B854B9-966B-4EAE-8C41-832CB9893491
P2860
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Early clinical and echocardiog ...... patients with aortic stenosis.
@ast
Early clinical and echocardiog ...... patients with aortic stenosis.
@en
type
label
Early clinical and echocardiog ...... patients with aortic stenosis.
@ast
Early clinical and echocardiog ...... patients with aortic stenosis.
@en
prefLabel
Early clinical and echocardiog ...... patients with aortic stenosis.
@ast
Early clinical and echocardiog ...... patients with aortic stenosis.
@en
P2093
P2860
P356
P1476
Early clinical and echocardiog ...... patients with aortic stenosis
@en
P2093
Andrew C Eisenhauer
Brian K Whisenant
Craig R Smith
Dean J Kereiakes
Girma M Ayele
Howard C Herrmann
John G Webb
Jonathon Leipsic
Jonathon White
Kevin L Greason
P2860
P304
P356
10.1093/EURHEARTJ/EHW112
P577
2016-03-31T00:00:00Z